Viewing Study NCT03630406


Ignite Creation Date: 2025-12-26 @ 5:23 PM
Ignite Modification Date: 2026-03-05 @ 5:42 AM
Study NCT ID: NCT03630406
Status: COMPLETED
Last Update Posted: 2020-09-16
First Post: 2018-08-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Vaginal Elasticity Assessment Before and After Vaginal Carbon Dioxide Laser Treatment.
Sponsor:
Organization:

Raw JSON

{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'COHORT'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 25}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2018-10-01', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2020-09', 'completionDateStruct': {'date': '2020-08-31', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2020-09-12', 'studyFirstSubmitDate': '2018-08-10', 'studyFirstSubmitQcDate': '2018-08-10', 'lastUpdatePostDateStruct': {'date': '2020-09-16', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2018-08-14', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2020-04-30', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Vaginal elasticity assessment', 'timeFrame': 'up to 3 months from enrollment', 'description': 'Vaginal elasticity as measured by the vaginal tactile imager'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['Laser Burn']}, 'descriptionModule': {'briefSummary': 'Female patients with either stress urinary incontinence (SUI) or vaginal wall weakness and prolapse will be evaluated for vaginal elasticity using vaginal tactile imaging both before and after Carbon Dioxide laser treatment.', 'detailedDescription': "Patients will be recruited and sign a consent form. The patients included are patients with SUI or vaginal wall weakness and prolapse. Each participant undergoes 3 laser treatments 4 weeks apart.\n\nAssessment of vaginal elasticity via vaginal tactile imaging will be performed at 3 different points:\n\n* Before the first treatment session (baseline).\n* Before and after each treatment session.\n* 3 months post final treatment. Every patient will serve as her own control. Demographic, gynecologic and obstetric history will be obtained from patients' electronic files."}, 'eligibilityModule': {'sex': 'FEMALE', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'maximumAge': '75 Years', 'minimumAge': '18 Years', 'genderBased': True, 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Female patients with either SUI or vaginal wall weakness and prolapse.', 'genderDescription': 'Female patients.', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Any woman undergoing vaginal Carbon Dioxide laser treatment.\n\nExclusion Criteria:\n\n* Women that are not in the age range.'}, 'identificationModule': {'nctId': 'NCT03630406', 'briefTitle': 'Vaginal Elasticity Assessment Before and After Vaginal Carbon Dioxide Laser Treatment.', 'organization': {'class': 'OTHER', 'fullName': 'Rambam Health Care Campus'}, 'officialTitle': 'Vaginal Elasticity Assessment Before and After Vaginal Carbon Dioxide Laser Treatment.as Measured by Vaginal Tactile Imaging.', 'orgStudyIdInfo': {'id': '0022-18-RMB'}}, 'armsInterventionsModule': {'armGroups': [{'label': 'Laser treatment', 'description': 'Female patients with either SUI of vaginal wall weakness and prolapse refered for an attempt at laser treatment.', 'interventionNames': ['Diagnostic Test: Vaginal Tactile Imaging']}], 'interventions': [{'name': 'Vaginal Tactile Imaging', 'type': 'DIAGNOSTIC_TEST', 'description': 'Vaginal Tactile Imaging', 'armGroupLabels': ['Laser treatment']}]}, 'contactsLocationsModule': {'locations': [{'city': 'Haifa', 'country': 'Israel', 'facility': 'Rambam health care campus', 'geoPoint': {'lat': 32.81303, 'lon': 34.99928}}], 'overallOfficials': [{'name': 'Roy Lauterbach, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Principal Investigator'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'UNDECIDED'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Rambam Health Care Campus', 'class': 'OTHER'}, 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Primary Investigator', 'investigatorFullName': 'ROY LAUTERBACH MD', 'investigatorAffiliation': 'Rambam Health Care Campus'}}}}